Loading…
LifeMD, Inc. is projected to rise to $6.98 by 2027, a +50% move from its current price of $4.64. LFMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.47 | $4.64 | $4.82 | 0.00% |
| Jul 14 | $4.40 | $4.64 | $4.89 | 0.00% |
| Jul 15 | $4.35 | $4.64 | $4.95 | 0.00% |
| Jul 16 | $4.30 | $4.64 | $5.00 | 0.00% |
| Jul 17 | $4.27 | $4.64 | $5.05 | 0.00% |
| Jul 18 | $4.23 | $4.64 | $5.09 | 0.00% |
| Jul 19 | $4.20 | $4.64 | $5.13 | 0.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.20 | $4.64 | $5.13 | 0.00% |
| Week 2 | $4.03 | $4.64 | $5.34 | +0.01% |
| Week 3 | $3.91 | $4.64 | $5.51 | +0.01% |
| Week 4 | $3.80 | $4.64 | $5.66 | +0.02% |
| Week 5 | $3.71 | $4.64 | $5.80 | +0.02% |
| Week 6 | $3.64 | $4.64 | $5.92 | +0.02% |
| Week 7 | $3.57 | $4.64 | $6.04 | +0.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LifeMD, Inc. operates as a direct-to-patient telehealth company providing access to virtual medical care and pharmacy services in the United States. Its platform includes Rex MD, a men’s telehealth service that offers virtual diagnosis, treatment, and prescription medications for men’s health conditions such as erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety.
It also includes ShapiroMD, which provides virtual medical treatment, patented doctor formulated OTC products, topical compounded medications, and medical devices treating hair loss in men and women.
LifeMD, Inc. (LFMD) is a healthcare company offering telehealth and in-home care services. It is headquartered in New York, New York and operates in the healthcare category with a direct-to-patient model.
The current price is $4.87 and the market capitalization is $235.53M, with a market rank of 3609. The latest price outlook shows a path of growth with a long-run bullish forecast, though near-term results remain uncertain.
A major floor 37.3% below — a decisive break under it would weaken the trend.
The nearest floor, 11.0% below — buyers have tended to step in here.
The nearest ceiling, 8.2% above — a clean break opens room to run.
A major ceiling 18.2% above — clearing it would confirm fresh momentum.
Key LFMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LFMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.77 | Sell | $4.69 | Sell |
| MA 10 | $4.57 | Buy | $4.65 | Sell |
| MA 20 | $4.61 | Buy | $4.62 | Buy |
| MA 50 | $4.61 | Buy | $4.51 | Buy |
| MA 100 | $4.13 | Buy | $4.41 | Buy |
| MA 200 | $4.34 | Buy | $4.75 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.89 | Neutral |
| Stoch RSI (14) | 61.01 | Neutral |
| CCI (20) | 7.52 | Neutral |
| Williams %R (14) | -34.62 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 1.98 | Buy |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 65.38 | Neutral |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | 0.16 | Buy |
| Ultimate (7,14,28) | 62.80 | Neutral |
| Momentum (10) | 0.44 | Buy |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 4.79 | Sell |
| ADX (14) | 10.63 | Neutral |
| ATR (14) | 0.15 | Info |
Near-term sentiment is bullish with an RSI of 60, suggesting room for upside. The stock’s 50-day simple moving average sits at $4.59, above the 200-day average of $4.37, signaling a mild positive trend. In the next 30 days, the range is $3.67 to $6.45, with support at $4.07 and resistance at $5.02.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.64 | $4.64 | $6.49 | 0% | Neutral | |
| $5.36 | $6.98 | $9.72 | +50% | Bullish | |
| $6.91 | $9.36 | $13.69 | +102% | Bullish | |
| $7.07 | $9.90 | $15.03 | +113% | Bullish | |
| $7.54 | $10.89 | $17.06 | +135% | Bullish | |
| $8.59 | $12.75 | $20.51 | +175% | Bullish | |
| $8.17 | $12.44 | $20.51 | +168% | Bullish | |
| $9.68 | $15.11 | $25.45 | +226% | Bullish | |
| $12.61 | $20.15 | $34.64 | +334% | Bullish | |
| $13.63 | $22.28 | $39.01 | +380% | Bullish | |
| $17.83 | $32.38 | $61.19 | +598% | Bullish | |
| $33.99 | $74.76 | $157.67 | +15.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.64 | $4.64 | $5.64 | +0.00% |
| August 2026 | $3.80 | $4.54 | $5.59 | -2.25% |
| September 2026 | $3.85 | $4.64 | $5.81 | +2.35% |
| October 2026 | $4.07 | $4.94 | $6.26 | +6.46% |
| November 2026 | $4.07 | $4.98 | $6.37 | +0.75% |
| December 2026 | $4.08 | $5.02 | $6.49 | +0.84% |
Click any year to see its month-by-month LFMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect LFMD to range from $2.64 to $6.49 through 2026. The $4.64 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The LFMD price prediction for 2027 points to an average of $6.98 (low $5.36, high $9.72) — a potential gain of +50% on today's $4.64. Buyers look set to stay in control over this stretch.
In 2028, LFMD is projected to trade between $6.91 and $13.69, averaging $9.36 — a potential gain of +102% from today's $4.64. That is up +34% on the projected 2027 average. Momentum favours further upside here.
LifeMD, Inc.'s 2029 outlook centres on $9.90, within a $7.07 to $15.03 range. That is up +6% on the projected 2028 average. That marks a +113% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, LFMD could reach as high as $17.06, with a base case around $10.89 and support toward $7.54 — roughly +135% from $4.64. Momentum favours further upside here.
Expect LFMD to range from $8.59 to $20.51 through 2031. The $12.75 average target implies a +175% move from current prices. That is up +17% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The LFMD price prediction for 2032 points to an average of $12.44 (low $8.17, high $20.51) — a potential gain of +168% on today's $4.64. Momentum favours further upside here.
In 2033, LFMD is projected to trade between $9.68 and $25.45, averaging $15.11 — a potential gain of +226% from today's $4.64. That is up +21% on the projected 2032 average. Buyers look set to stay in control over this stretch.
LifeMD, Inc.'s 2034 outlook centres on $20.15, within a $12.61 to $34.64 range. That is up +33% on the projected 2033 average. That marks a +334% change versus current levels. Momentum favours further upside here.
By 2035, LFMD could reach as high as $39.01, with a base case around $22.28 and support toward $13.63 — roughly +380% from $4.64. Buyers look set to stay in control over this stretch.
Expect LFMD to range from $17.83 to $61.19 through 2040. The $32.38 average target implies a +598% move from current prices. That is up +45% on the projected 2035 average. Momentum favours further upside here.
The LFMD price prediction for 2050 points to an average of $74.76 (low $33.99, high $157.67) — a potential gain of +15.1x on today's $4.64. Buyers look set to stay in control over this stretch.
Investing $1,000 in LFMD today (≈ 215.517241 LFMD) could be worth
$16,111.13
+$15,111.13 (+1511%) by 2050 · US Dollar
Based on the average projected LFMD price of $74.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LFMDwould be worth at today's price.
$1,000 invested in LFMD on Jul 10, 2025 (≈ 83.61204 LFMD) would be worth
$387.96
-$612.04 (-61.2%) today · 0.39× · US Dollar
Based on a LFMD entry price of $11.96 vs. today's $4.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.87 | $952.77 | -4.7% |
| 1 month ago | $4.97 | $933.6 | -6.6% |
| 3 months ago | $3.47 | $1,337.18 | +33.7% |
| 6 months ago | $4.19 | $1,107.4 | +10.7% |
| 1 year ago | $11.96 | $387.96 | -61.2% |
| All time (5.0y) ago | $9.72 | $477.37 | -52.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LFMD forecast.
Our base-case forecast reaches $9.30 around 2028.
Implied market cap at $9.30: $449.77M
The multi-year forecast shows rising averages and meaningful upside. For 2026 the average price is $4.87 with a neutral sentiment. From 2027 onward, the forecast shifts to bullish, with 2027 average $8.12 and 2030 average $13.24, yielding a 171.8% ROI.
By 2040 the average is $45.65 (837.3% ROI) and by 2050 the average reaches $111.38 (2,187.1% ROI). The forecast also notes progressively higher price targets across successive years, reflecting strong long-run upside but these are estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $13.24 with a max of $21.47 and a min of $8.84, and a projected ROI of 171.8% with bullish sentiment.
Forecasts indicate a bullish trend from 2027 through 2050, with rising averages and substantial ROIs, including 171.8% in 2030, 837.3% in 2040, and 2,187.1% in 2050. These are estimates and not guarantees.
Yes. The 2050 forecast shows a min of $50.12 and an average of $111.38, indicating the potential to reach or exceed $50 in 2050 according to the projections.
The current price is $4.87.
The market capitalization is $235.53M.
LifeMD, Inc. Community Discussion
0Share your LifeMD, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.